Evidence map›Paper›PMID 18256785›Full record

ArticleInternational journal of hematology2008

Tumor necrosis factor-alpha enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway.

Hong-Nu Yu, Young-Rae Lee, Eun-Mi Noh, Kyung-Sun Lee, Eun-Kyung Song, Myung-Kwan Han, Yong-Chul Lee, Chang-Yeol Yim, Jinny Park, Byeong-Soo Kim and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Anti-leukemic principle(s) fromCytotechnology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Hierarchical scaffolding of an ERK1/2 activation pathway.Cell communication and signaling : CCS · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Hong-Nu YuDepartment of Biochemistry, Institute of Medical Science, Chonbuk National University Medical School, Jeonju, Jeonbuk, 560-180, South Korea.
Young-Rae LeeDepartment of Biochemistry, Institute of Medical Science, Chonbuk National University Medical School, Jeonju, Jeonbuk, 560-180, South Korea.
Eun-Mi NohDepartment of Biochemistry, Institute of Medical Science, Chonbuk National University Medical School, Jeonju, Jeonbuk, 560-180, South Korea.
Kyung-Sun LeeDepartment of Biochemistry, Institute of Medical Science, Chonbuk National University Medical School, Jeonju, Jeonbuk, 560-180, South Korea.
Eun-Kyung SongDepartment of Microbiology and Immunology, Chonbuk National University Medical School, Jeonju, South Korea.
Myung-Kwan HanDepartment of Microbiology and Immunology, Chonbuk National University Medical School, Jeonju, South Korea.
Yong-Chul LeeDepartment of Internal Medicine, Research Center for Allergic Immune Diseases, Chonbuk National University Medical School, Jeonju, South Korea.
Chang-Yeol YimDepartment of Internal Medicine, Research Center for Allergic Immune Diseases, Chonbuk National University Medical School, Jeonju, South Korea.
Jinny ParkDivision of Hematology/Oncology, Gachon University Medical Center, Inchon, South Korea.
Byeong-Soo KimDepartment of Companion and Laboratory Animal Science, Kongju National University, Kongju, South Korea.
Sung-Ho LeeDepartment of Companion and Laboratory Animal Science, Kongju National University, Kongju, South Korea.
Seung Jin LeeDepartment of Pharmacy, College of Pharmacy, Ewha Womans University, Seoul, South Korea.
Jong-Suk KimDepartment of Biochemistry, Institute of Medical Science, Chonbuk National University Medical School, Jeonju, Jeonbuk, 560-180, South Korea. jsukim@chonbuk.ac.kr.
Jeonbuk National University · KREwha Womans University · KRGachon University · KRKongju National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The differentiation of promyelocytic leukemic cells into mature cells is the major strategy for drug-based treatment of leukemia. Higher efficient methods to differentiate promyelocytic leukemic cells have been developed using various differentiation inducers including interferon-alpha, interleukin-4, tumor necrosis factor-alpha (TNF-alpha), and dimethyl sulfoxide (DMSO) as a single agent or in combination with each other. Here, we show that a combination of TNF-alpha with DMSO shows a synergic effect on HL-60 cell differentiation through the activation of ERK pathway. TNF-alpha enhanced CD11b expression and percent of cell population in the G1 phase induced by DMSO, which are hallmarks for HL-60 cell differentiation. Inhibition of ERK pathway abolished the synergic effect of TNF-alpha in combination with DMSO on HL-60 differentiation, but the inhibition NF-kappaB pathway did not. These results suggest that TNF-alpha synergistically increases DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK-signaling pathway.

Indexed as

Cell DifferentiationDimethyl SulfoxideDrug SynergismDrug Therapy, CombinationGranulocyte Precursor CellsHL-60 CellsHumansMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphorylationTumor Necrosis Factor-alphaDimethyl SulfoxideMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Tumor Necrosis Factor-alpha

Identifiers

PMID18256785
OpenAlexW2031725268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.